10.10.24 -- Meeting The Demand For Cell & Gene Therapy Commercialization

Catalent’s UpTempo AAV platform process is a scalable, cGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half.

Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, shares insight into how the standardization process can help reduce project timelines and overall costs.

Learn how leveraging a GMP-like environment even in early R&D stages is crucial for setting your cell therapy up for success as you advance toward IND and NDA approvals.

GC Cell fully understands the unique challenges around CGT development and manufacturing. Explore our end-to-end, customer-centric CDMO services that are helping to bring more breakthrough treatments to patients.

Find the right strategic partnership to leverage proven expertise as well as established manufacturing processes and analytical methods to reach patients in record time.

Discover better logistics support for the pharmaceutical, biotechnology, and medical device industries with high-quality kit packing and distribution through in-house kit-building facilities. 

A CDMO that manufactures nucleases at research and cGMP grades can eliminate the need for custom manufacturing runs, simplify the transition to clinical application, and reduce regulatory paperwork.

As a CDMO Partner for Life™, our goal is to advance your cell therapies from lab to commercial scale, leveraging our cell and gene therapy expertise and global cGMP network.

Our robust analytical capabilities support development processes and ensure our products are well characterized, safe and meet regulatory guidelines.

Ajinomoto Bio-Pharma Services stands at the forefront of oligonucleotide and peptide manufacturing, offering a transformative approach to production through its innovative AJIPHASE technology.

In cell and gene therapies, your process is the product. Our team of experts develops, defines, and refines processes for maximum efficiency and scale.

Our expertise and capabilities allowed us to produce our own HEK293 production cell lines utilizing a wide variety of upstream platforms including iCellis, Cell Stacks, Univercells, and Stirred-Tank Reactors.

TrakCel, a leading supplier of cellular orchestration solutions for clinical trials and commercial therapies to the CGT industry, partnered with Cencora to launch an integrated technology platform.

Andelyn Biosciences is your full-spectrum gene therapy partner. Work with us from start to finish of your product or partner with us at any stage of your project – preclinical through commercial scale.